421 related articles for article (PubMed ID: 11851893)
1. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
[TBL] [Abstract][Full Text] [Related]
2. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
Fontao L; Tasanen K; Huber M; Hohl D; Koster J; Bruckner-Tuderman L; Sonnenberg A; Borradori L
J Invest Dermatol; 2004 Jan; 122(1):65-72. PubMed ID: 14962091
[TBL] [Abstract][Full Text] [Related]
3. Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex.
Jonkman MF; Pas HH; Nijenhuis M; Kloosterhuis G; Steege G
J Invest Dermatol; 2002 Dec; 119(6):1275-81. PubMed ID: 12485428
[TBL] [Abstract][Full Text] [Related]
4. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
[TBL] [Abstract][Full Text] [Related]
5. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.
Pasmooij AM; van der Steege G; Pas HH; Smitt JH; Nijenhuis AM; Zuiderveen J; Jonkman MF
Br J Dermatol; 2004 Sep; 151(3):669-74. PubMed ID: 15377356
[TBL] [Abstract][Full Text] [Related]
6. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain.
Tasanen K; Floeth M; Schumann H; Bruckner-Tuderman L
J Invest Dermatol; 2000 Aug; 115(2):207-12. PubMed ID: 10951237
[TBL] [Abstract][Full Text] [Related]
7. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
[TBL] [Abstract][Full Text] [Related]
8. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
[TBL] [Abstract][Full Text] [Related]
9. A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.
Pasmooij AM; van Zalen S; Nijenhuis AM; Kloosterhuis AJ; Zuiderveen J; Jonkman MF; Pas HH
Exp Dermatol; 2004 Feb; 13(2):125-8. PubMed ID: 15009107
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.
Pulkkinen L; Marinkovich MP; Tran HT; Lin L; Herron GS; Uitto J
J Invest Dermatol; 1999 Dec; 113(6):1114-8. PubMed ID: 10636730
[TBL] [Abstract][Full Text] [Related]
12. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
[TBL] [Abstract][Full Text] [Related]
13. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
14. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.
Pulkkinen L; Uitto J
Exp Dermatol; 1998; 7(2-3):46-64. PubMed ID: 9583744
[TBL] [Abstract][Full Text] [Related]
15. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.
Bauer JW; Lanschuetzer C
Clin Exp Dermatol; 2003 Jan; 28(1):53-60. PubMed ID: 12558632
[TBL] [Abstract][Full Text] [Related]
16. Loss of interaction between plectin and type XVII collagen results in epidermolysis bullosa simplex.
Natsuga K; Nishie W; Nishimura M; Shinkuma S; Watanabe M; Izumi K; Nakamura H; Hirako Y; Shimizu H
Hum Mutat; 2017 Dec; 38(12):1666-1670. PubMed ID: 28941359
[TBL] [Abstract][Full Text] [Related]
17. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
[TBL] [Abstract][Full Text] [Related]
18. BP180 (type XVII collagen) and its role in cutaneous biology and disease.
Van den Bergh F; Giudice GJ
Adv Dermatol; 2003; 19():37-71. PubMed ID: 14626817
[TBL] [Abstract][Full Text] [Related]
19. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
Floeth M; Bruckner-Tuderman L
Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
[TBL] [Abstract][Full Text] [Related]
20. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
